Paul Sargos

6PUBLICATIONS
20CO-AUTHORS
Predictive and prognostic markersRadiation therapyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 02, 2026
Temozolomide Versus Radiotherapy as First-Line Therapy for Low-Grade Glioma: Mature Results of a Randomized Phase III Trial (EORTC 22033-26033/NCIC-CTG/TROG/MRC-CTU).

|Jun 18, 2025
Optimizing salvage radiotherapy in prostate cancer: the emerging role of prostate-specific membrane antigen positron emission tomography/computed tomography.

Elísabet Gonzalez Del Portillo, Fernando López-Campos, Paul Sargos

|Sep 19, 2023
Stereotactic body radiation therapy after radical prostatectomy: current status and future directions.

Jennifer Le Guevelou, Nicolas Magne, Felipe Counago

|Sep 11, 2020
Combined radiotherapy and immunotherapy in urothelial bladder cancer: harnessing the full potential of the anti-tumor immune response.

Mame Daro-Faye, Wassim Kassouf, Luis Souhami

|Apr 05, 2019
Long-term androgen deprivation, with or without radiotherapy, in locally advanced prostate cancer: updated results from a phase III randomised trial.

Paul Sargos, Nicolas Mottet, Carine Bellera

|Apr 07, 2017
Adjuvant radiotherapy after radical cystectomy for muscle-invasive bladder cancer: A retrospective multicenter study.

Mathieu Orré, Igor Latorzeff, Aude Fléchon

Pageof 1

Frequent Collaborators

1 joint publications

Elísabet Gonzalez Del Portillo

1 joint publications

Fernando López-Campos

1 joint publications

Felipe Couñago

1 joint publications

Brigitta G Baumert